Spectrum Chemical: The Right Ingredients Backed by Quality Control
Fast Pharma: Balancing Risk and Quality with Time to Market
The complex journey of pharmaceutical discovery and development ideally leads to successful product commercialization that will address patients’ medicinal needs worldwide, but the path from discovery to launch often requires a careful calculation involving risk and the standardization of quality in a global environment. This article will discuss some of the top challenges facing drug developers and how R&D scientists and procurement specialists are working together to bring new products to market faster while ensuring quality.
The new Drug and Supply Chain Security Act (DSCSA) and other regulations are intended to keep small-molecule and biologic drugs safe in an increasingly fragmented pharmaceutical ecosystem. The complexity of a globalized chemical industry, in which chemicals and reagents used to make a drug may originate in multiple countries, enhances efficiencies but can also increase risks, and regulations may differ from country to country. This ebook will highlight the coming changes in regulations that apply to drug manufacturers, the need for and application of these regulations in both the small-molecule and biologic drug arenas, and the challenges of maintaining a robust, safe drug supply chain.
Meet increasing quality, safety and regulatory requirements with confidence with Spectrum Chemical's bioCERTIFIED™ Quality Management System and products for biopharmaceutical manufacturing. Featuring expanded laboratory testing, certifications and scientific documentation, our bioCERTIFIED portfolio is tailored to each customer’s unique requirements from biopharmaceutical drug discovery to pilot and scale-up to production.
The Solution Lies with SOLBIOTE™: Achieving Sustainability, a Growing Focus in Biopharma
October 28th 2024The nexus between biopharmaceuticals and sustainability is seemingly far apart, however, it is increasingly recognized as an inevitable challenge. It is encouraged to take a sustainable approach to reducing the environmental impact of the production and supply of medicines while improving people's health; delivering the well-being of people and the planet. Yosuke Shimojo (Technical Value Support Section Manager, Nagase Viita) will unveil how SOLBIOTE™, a portfolio of injectable-grade saccharide excipients, would be a key for the biopharmaceutical development and achieving sustainability for a better future of the industry.
